MARIANI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 11.535
NA - Nord America 497
AS - Asia 102
OC - Oceania 2
AF - Africa 1
Totale 12.137
Nazione #
IT - Italia 11.377
US - Stati Uniti d'America 489
SE - Svezia 90
CN - Cina 42
IN - India 19
SG - Singapore 15
FI - Finlandia 13
NL - Olanda 12
DE - Germania 11
GB - Regno Unito 10
CA - Canada 7
ES - Italia 6
FR - Francia 5
HK - Hong Kong 5
KR - Corea 5
IR - Iran 4
TH - Thailandia 4
UA - Ucraina 4
VN - Vietnam 4
GR - Grecia 3
AU - Australia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 12.137
Città #
Cagliari 11.308
Nyköping 79
Fairfield 72
Chandler 67
Ashburn 42
Boardman 31
Houston 31
Wilmington 28
Cambridge 26
Seattle 24
Woodbridge 22
San Diego 17
Shanghai 17
New York 16
Boston 15
Helsinki 13
Pune 13
Rome 11
Amsterdam 8
Toronto 7
Menlo Park 5
Pamplona 5
Seoul 5
Beijing 4
Dearborn 4
Dong Ket 4
Hefei 4
Jacksonville 4
Nanjing 4
Naples 4
Singapore 4
London 3
Peristeri 3
Turin 3
Ann Arbor 2
Centro 2
Chicago 2
Delhi 2
Don Mueang 2
Enna 2
Hong Kong 2
Islington 2
Kyjov 2
Livorno 2
Los Angeles 2
Norwalk 2
Paris 2
Romainville 2
San Francisco 2
San Mateo 2
Sydney 2
Xian 2
Zhengzhou 2
Alexandria 1
Amgaon 1
Ankara 1
Assèmini 1
Bergamo 1
Bilbao 1
Cairo 1
Chandigarh 1
Exeter 1
Frattamaggiore 1
Gela 1
Hangzhou 1
Heidelberg 1
Kilburn 1
Lecce 1
Lviv 1
Magelang 1
Milan 1
Naaldwijk 1
Nanchang 1
Nanterre 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Redwood City 1
Rockville 1
Sambuca di Sicilia 1
Shaoxing 1
Shenzhen 1
Sindelfingen 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Torino 1
Totale 11.977
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 2.512
Molecular-biology-driven treatment for metastatic colorectal cancer 2.119
New therapeutic targets in pancreatic cancer 1.309
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.252
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 609
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 480
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 475
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 452
Uncovering key targets of success for immunotherapy in pancreatic cancer 413
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 356
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 349
BRCA-mutant pancreatic ductal adenocarcinoma 340
Immune Checkpoint Inhibitors in the Treatment of HCC 340
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 317
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 302
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study 294
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 272
Totale 12.191
Categoria #
all - tutte 17.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 0 0 22
2019/2020893 47 19 6 12 254 210 182 35 20 33 23 52
2020/20213.495 69 102 66 1.186 649 407 144 235 102 224 185 126
2021/20221.575 100 73 19 72 69 105 77 140 103 168 290 359
2022/20233.541 359 512 414 287 331 360 189 203 203 219 270 194
2023/20242.572 144 109 101 159 231 470 513 206 141 157 256 85
Totale 12.191